Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VARELISA GLIADIN IGG ANTIBODIES

K-Number: K041357 · 2004-08-02

ApplicantSweden Diagnostics (Germany) GmbH
Decision Date2004-08-02
Product CodeMST
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

VARELISA GLIADIN IGG ANTIBODIES is the device name listed in this FDA 510(k) record. The listed applicant is Sweden Diagnostics (Germany) GmbH. It received FDA 510(k) clearance on 2004-08-02 under 510(k) number K041357. The device is classified under product code MST. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VARELISA GLIADIN IGG ANTIBODIES?

VARELISA GLIADIN IGG ANTIBODIES is a medical device that received FDA 510(k) clearance on 2004-08-02. The listed applicant is Sweden Diagnostics (Germany) GmbH. The 510(k) number is K041357.

When did VARELISA GLIADIN IGG ANTIBODIES receive FDA 510(k) clearance?

VARELISA GLIADIN IGG ANTIBODIES received FDA 510(k) clearance on 2004-08-02, under 510(k) number K041357.

Who is the listed applicant for VARELISA GLIADIN IGG ANTIBODIES?

The FDA 510(k) record lists Sweden Diagnostics (Germany) GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VARELISA GLIADIN IGG ANTIBODIES?

The FDA product code for VARELISA GLIADIN IGG ANTIBODIES is MST.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Sweden Diagnostics (Germany) GmbH as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K050967VARELISA RECOMBI CTD SCREEN, MODEL 13096K050625VARELISA RECOMBI ANA PROFILE, MODEL 18496K042629VARELISA SM ANTIBODIES, MODEL 18296K041173CELIKEY IGG ITG IGG ANTIBODIES, MODEL 17996K041174CELIKEY TTG (HUMAN, RECOMBINANT) IGA ANTIBODIES MODEL #18148/18196K041354VARELISA GLIADIN IGA ANTIBODIES MODEL #19848/19896

View all 8 devices →

Related Devices (Code: MST)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K163177ImmuLisa Enhanced Gliadin IgA Antibody ELISA, ImmuLisa Enhanced Gliadin IgG Antibody ELISAImmco Diagnostics, Inc.K132082AESKULISA DGP-A, AESKULISA DGP-G,AESKULISA DGP-CHECKAesku DiagnosticsK113377GLIADIN IGA AND GLIADIN LGAGrifols USA, LLCK113863QUANTA FLASH DGP IGA, QUANTA FLASH DGP IGG, QUANTA FLASH DGP IGA CALIBRATORS, QUANTA FLASH DGP IGG CALIBRATORSInova Diagnostics, Inc.K111414QUANTA FLASH (TM) DGP SCREENInova Diagnostics, Inc.K093459ELIA GLIADIN DP IGA IMMUNOASSAY AND ELIA GLIADIN DP IGG IMMUNOASSAY, MODELS 14-5538-01, 14-5539-01Phadia US, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑